HB 278: TOXICOLOGY REIMBURSEMENT REQUIREMENTS
HB 278 status: Introduced — action postponed indefinitely (updated Mar 24, 2026).
What this bill does
Overall score
Bill summary
OfficialThe House is currently looking at a new bill about how doctors and labs get paid for drug testing.
Key analysis
Impact analysis
Environment
Benefits
- no identified direct effect on environmental regulation
Risks
- no identified direct effect on environmental regulation
Economy
Benefits
- potential for more predictable billing practices
Risks
- possible disruption to existing laboratory reimbursement models
Society
Benefits
- potential for increased transparency in clinical billing
Risks
- uncertain impact on the availability or cost of drug testing for patients
How trustworthy & consequential it is
Source
OpenStates
Confidence
lowlow
Analysis status
OpenStates summary
the bill was postponed indefinitely, suggesting lack of consensus or significant stakeholder opposition
analysis based solely on a high-level summary
Where it stands
Introduced
Currentaction postponed indefinitely
Committee
UpcomingFloor
UpcomingGovernor
UpcomingEnacted
UpcomingHow it affects your district
Set your location
Add your district to see how this bill may affect your community and who to contact.
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.